DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Cortes JE, Gambacorti-Passerini C, Deininger MW. et al.
Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial.
J Clin Oncol 2018;
36 (03) 231-237
Access:
We do not assume any responsibility for the contents of the web pages of other providers.